Solar Foods Oyj

Solar Foods Oyj has a liquidity position that is relatively strong, with a current ratio of 2.56, indicating that the company has more than twice the current assets to cover its current liabilities. However, the company's liquidity is constrained by a negative net cash position after subtracting total debt, which is a key flag in the risk assessment. The company's cash and equivalents amount to EUR 7,989,830, while its long-term debt is EUR 16,865,000, resulting in a net cash outflow of EUR 8,875,170. The company's profitability is currently negative, with a return on equity of -1.0008 and a return on assets of -0.3669, both of which are significantly below the industry median for biotechnology and medical research firms. The operating income is negative at EUR -10,400,340, and the net income is also negative at EUR -11,517,600, indicating that the company is not yet generating positive returns for its shareholders. Solar Foods operates in a single business segment focused on producing protein from air, with no disclosed geographic diversification in its revenue streams. The company's revenue for the latest period is EUR 123,590, which is relatively small in scale, and there is no indication of significant geographic expansion or diversification in the near term. The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current fiscal year or the next. The operating cash flow is negative at EUR -2,129,970, and the free cash flow is also negative at EUR -8,295,270, suggesting that the company is not generating sufficient cash to fund its operations or expansion. The capital expenditure of EUR -6,239,000 indicates that the company is investing in its operations, but the negative cash flows suggest that these investments are not yet yielding returns. The risk assessment for Solar Foods highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 1.47 indicates that it is leveraged, but the dilution risk is low, with no significant dilution expected in the near term. The company's capital structure is dominated by long-term debt, which could pose a risk if interest rates rise or if the company is unable to service its debt obligations. Recent events and disclosures indicate that the company is in a development phase, with no strong buy recommendations from analysts. The mean price target is EUR 4.67, with a high of EUR 5.30 and a low of EUR 4.05, suggesting a relatively narrow range of expectations among analysts. The company has not received any strong buy or buy ratings, with all analyst recommendations being neutral or hold.